JAGSONPAL PHARMACEUTICALS LTD.

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	166.83	126.6	145.07	144.19	139.09
Other Income	1.43	0.46	13.27	0.66	0.11
Stock Adjustments	-19.42	4.08	8.39	6.22	1.65
Total Income	148.84	131.14	166.73	151.07	140.85
EXPENDITURE :
Raw Materials	53.43	65.19	67.34	65.35	70.33
Excise Duty	0	0.07	1.2	0.7	0.94
Power and Fuel Cost	1.41	1	2.12	2.26	1.77
Other Manufacturing Expenses	0.73	0.96	1.34	1.7	1.01
Employee Cost	46.61	41.88	40.95	37.84	32.11
Selling and Administration Expenses	32.23	27.56	30.19	26.58	21.17
Miscellaneous Expenses	3.66	5.14	4.56	4.19	4.67
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	10.77	-10.65	19.03	12.47	8.84
Interest and Financial Charges	0.75	0.66	2.64	5.3	4.46
Profit before Depreciation and Tax	10.02	-11.31	16.39	7.17	4.38
Depreciation	1.02	0.32	1.99	3.09	2.71
Profit Before Tax	9.01	-11.63	14.39	4.07	1.67
Tax	1.79	-0.08	2.53	0.82	0.5
Profit After Tax	7.22	-11.55	11.86	3.25	1.17
Adjustment below Net Profit	0	0	0	0	0
P and L Balance brought forward	34.71	46.57	35.22	32.48	31.83
Appropriations	0.79	0.32	0.52	0.52	0.51
P and L Bal. carried down	41.13	34.71	46.57	35.22	32.48
Equity Dividend	0.79	0.32	0.32	0.26	0.26
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0.05	0.05
Equity Dividend (%)	5	2	2	2	2
Earning Per Share (Rs.)	2.75	0	4.53	1.22	0.45
Book Value	36.89	34.43	38.96	34.55	33.43
Extraordinary Items	0	0	12.8	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

166.83

126.6

145.07

144.19

139.09

Other Income

1.43

0.46

13.27

0.66

0.11

Stock Adjustments

-19.42

4.08

8.39

6.22

1.65

Total Income

148.84

131.14

166.73

151.07

140.85

EXPENDITURE :

Raw Materials

53.43

65.19

67.34

65.35

70.33

Excise Duty

0.07

1.2

0.7

0.94

Power and Fuel Cost

1.41

2.12

2.26

1.77

Other Manufacturing Expenses

0.73

0.96

1.34

1.7

1.01

Employee Cost

46.61

41.88

40.95

37.84

32.11

Selling and Administration Expenses

32.23

27.56

30.19

26.58

21.17

Miscellaneous Expenses

3.66

5.14

4.56

4.19

4.67

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

10.77

-10.65

19.03

12.47

8.84

Interest and Financial Charges

0.75

0.66

2.64

5.3

4.46

Profit before Depreciation and Tax

10.02

-11.31

16.39

7.17

4.38

Depreciation

1.02

0.32

1.99

3.09

2.71

Profit Before Tax

9.01

-11.63

14.39

4.07

1.67

Tax

1.79

-0.08

2.53

0.82

0.5

Profit After Tax

7.22

-11.55

11.86

3.25

1.17

Adjustment below Net Profit

P and L Balance brought forward

34.71

46.57

35.22

32.48

31.83

Appropriations

0.79

0.32

0.52

0.51

P and L Bal. carried down

41.13

34.71

46.57

35.22

32.48

Equity Dividend

0.79

0.32

0.26

Preference Dividend

Corporate Dividend Tax

0.05

Equity Dividend (%)

Earning Per Share (Rs.)

2.75

4.53

1.22

0.45

Book Value

36.89

34.43

38.96

34.55

33.43

Extraordinary Items

12.8

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	13.1	13.1	13.1	13.1	13.1
Reserves and Surplus	91.37	84.95	96.82	85.27	82.33
Total Shareholders Funds	104.47	98.05	109.92	98.37	95.43
Secured Loans	-2.29	0.02	0	30.35	32.83
Unsecured Loans	6.08	8.28	7.93	8.14	6.48
Total Debt	3.79	8.3	7.93	38.49	39.31
Total Liabilities	108.26	106.35	117.85	136.86	134.74
APPLICATION OF FUNDS :
Gross Block	55	53.66	52.88	90.35	87.61
Less: Accum. Depreciation	33.36	32.34	31.28	38.74	35.65
Net Block	21.64	21.32	21.6	51.61	51.96
Capital Work in Progress	3.95	3.04	0	0	0
Investments	0	0	0	0	0
Current Assets, Loans and Advances
Inventories	32.69	51.43	47.62	39.84	33.06
Sundry Debtors	20.75	25.15	39.41	41.69	44.89
Cash and Bank Balance	38.53	14.51	20.06	15.53	15.02
Loans and Advances	18.27	14.36	13.92	10.61	9.29
Less: Current Liab. and Prov.
Current Liabilities	20.65	18.37	19.36	19.95	17.72
Provisions	6.95	5.09	5.41	2.48	1.77
Net Current Assets	82.64	81.99	96.24	85.24	82.77
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	108.23	106.35	117.84	136.85	134.73
Contingent Liabilities	0.69	2.37	2.35	3.13	3.32

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

13.1

Reserves and Surplus

91.37

84.95

96.82

85.27

82.33

Total Shareholders Funds

104.47

98.05

109.92

98.37

95.43

Secured Loans

-2.29

0.02

30.35

32.83

Unsecured Loans

6.08

8.28

7.93

8.14

6.48

Total Debt

3.79

8.3

7.93

38.49

39.31

Total Liabilities

108.26

106.35

117.85

136.86

134.74

APPLICATION OF FUNDS :

Gross Block

53.66

52.88

90.35

87.61

Less: Accum. Depreciation

33.36

32.34

31.28

38.74

35.65

Net Block

21.64

21.32

21.6

51.61

51.96

Capital Work in Progress

3.95

3.04

Investments

Current Assets, Loans and Advances

Inventories

32.69

51.43

47.62

39.84

33.06

Sundry Debtors

20.75

25.15

39.41

41.69

44.89

Cash and Bank Balance

38.53

14.51

20.06

15.53

15.02

Loans and Advances

18.27

14.36

13.92

10.61

9.29

Less: Current Liab. and Prov.

Current Liabilities

20.65

18.37

19.36

19.95

17.72

Provisions

6.95

5.09

5.41

2.48

1.77

Net Current Assets

82.64

81.99

96.24

85.24

82.77

Miscellaneous Expenses not w/o

Total Assets

108.23

106.35

117.84

136.85

134.73

Contingent Liabilities

0.69

2.37

2.35

3.13

3.32

JAGSONPAL PHARMACEUTICALS LTD.

Enjoy Lifetime Free Delivery Trade